Alzheimer's disease, a form of dementia, profoundly impacts clinical neuroscience by challenging our understanding of memory, cognition, and neural degeneration. Clinically, it manifests through progressive memory loss, cognitive decline, and behavioral changes, affecting millions worldwide. Neuroscience research delves into the pathological mechanisms involving beta-amyloid plaques and tau protein tangles, which disrupt neural communication and lead to neuronal death. Imaging techniques like MRI and PET scans aid in diagnosis by revealing brain atrophy and metabolic changes. Treatment focuses on managing symptoms and slowing progression, yet a cure remains elusive. Clinical trials explore new therapies targeting disease mechanisms, offering hope for future breakthroughs. Understanding Alzheimer's through clinical neuroscience is crucial for developing effective interventions and improving the quality of life for those affected by this devastating condition.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States